Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defining Neurobiological Links Between Substance Use and Mental Illness
NCT05538910Recruiting
- Sponsor
- National Institute on Drug Abuse
- Start
- Feb 2023
- Primary completion
- Dec 2027
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Placebo First with Nicotine First (2 arms). Primary endpoints: Nicotine effects and symptoms of MDD, Task and Resting State Brain and 2 more. Started Feb 2023; status: recruiting.
02
Drugs
nicotine patch
Beyond the preview
Go deeper on NCT05538910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05538910.